Table 2.

Treatment-emergent adverse events from RRx-001

Adverse event	Any grade	Grades 3 or 4
Infusion site pain	6 (23%)	0 (0%)
Decreased appetite	4 (15.3%)	1 (3.8%)
Headache	3 (11.5%)	0 (0%)
Fatigue	2 (7.6%)	0 (0%)
Constipation	2 (7.6%)	0 (0%)
Nausea	2 (7.6%)	0 (0%)
Insomnia	2 (7.6%)	0 (0%)
Rash	2 (7.6%)	0 (0%)
Musculoskeletal pain	2 (7.6%)	1 (3.8%)
Hypomagnesemia	2 (7.6%)	1 (3.8%)
Hyperglycaemia	2 (7.6%)	1 (3.8%)
Anaemia	2 (7.6%)	0 (0%)